Dr. Paul Parren - Gilde Healthcare

team
Venture&Growth

All team members
Dr. Paul Parren
Operational Partner
The Netherlands

Dr. Paul Parren

Operational Partner

Paul Parren is an internationally recognized antibody drug innovator and developer. Paul was Head of Preclinical Development and Research at Genmab (2002-2017), translating antibody biology successfully into immunotherapies from discovery to the clinic, including approved therapeutic antibodies ofatumumab and daratumumab, as well as establishing validated antibody platform technologies. He is a Professor of Molecular Immunology at the Leiden University Medical Center in Leiden, the Netherlands, board member of The Antibody Society and was an Associate Professor at The Scripps Research Institute in La Jolla, California. He holds a PhD in Molecular Immunology from the University of Amsterdam.

Paul assists Gilde in the evaluation of investment opportunities and is also acting as Executive Vice President and Head of Research & Development for Gilde’s portfolio company Lava Therapeutics.

Renée van der Ven

Business Support Manager
Renée van der Ven joined Gilde Healthcare in 2017. She is responsible for Office Management within Gilde and supports the team members of Gilde Healthcare funds in the field of project management and event management....

Oksana van Vliet

Legal & AML/KYC counsel
Oksana van Vliet joined Gilde Healthcare in 2021 as Legal & AML/KYC Counsel. Her primary focus within Gilde Healthcare is to assist with legal, regulatory and compliance related matters. Oksana has over 10 years of...

Joep Muijrers

General Partner Public Investments
Venture&Growth
Joep Muijrers joined Gilde in 2021 with two decades of broad experience in life sciences, including senior roles in portfolio management, company operations and investment banking. Most recently, he served as Chief Financial Officer and...